Barchart.com
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Femasys Inc (FEMY)

Femasys Inc (FEMY)
1.1500 x 5 1.2400 x 1
Post-market by (Cboe BZX)
1.1900 -0.0400 (-3.25%) 04/04/25 [NASDAQ]
1.1500 x 5 1.2400 x 1
Post-market 1.1600 -0.0300 (-2.52%) 16:11 ET
News & Headlines for Fri, Apr 4th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic Stocktwits - Thu Mar 27, 1:44PM CDT

The company said that as of the end of 2024, it had an accumulated deficit of $127.2 million and cash and cash equivalents of only $3.5 million.

VXF : 155.35 (-5.26%)
VTI : 248.47 (-5.87%)
FEMY : 1.1900 (-3.25%)
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update GlobeNewswire - Thu Mar 27, 8:00AM CDT

FEMY : 1.1900 (-3.25%)
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations GlobeNewswire - Wed Mar 19, 8:20AM CDT

FEMY : 1.1900 (-3.25%)
Q1 Virtual Investor Summit: On-Demand Presentations Now Live ACCESS Newswire - Tue Mar 18, 10:30AM CDT

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / The Investor Summit is excited to announce that presentations from Q1 Investor Summit are now available for on-demand viewing. Attendees and investors...

SNANF : 0.1900 (-1.35%)
BRNS : 0.6820 (-10.26%)
FEMY : 1.1900 (-3.25%)
PERF : 1.6300 (-6.32%)
DRTS : 2.52 (+1.61%)
GIFT : 1.8600 (unch)
ROYIF : 0.0300 (-33.04%)
ZCAR : 3.56 (-4.04%)
CLNN : 2.69 (-11.80%)
MIND : 4.87 (-6.53%)
PYPD : 2.51 (-8.73%)
TOVX : 1.0800 (-8.47%)
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain GlobeNewswire - Tue Mar 18, 8:00AM CDT

FEMY : 1.1900 (-3.25%)
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach GlobeNewswire - Thu Mar 13, 7:30AM CDT

FEMY : 1.1900 (-3.25%)
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials GlobeNewswire - Tue Feb 25, 8:20AM CST

FEMY : 1.1900 (-3.25%)
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices GlobeNewswire - Tue Feb 11, 8:00AM CST

FEMY : 1.1900 (-3.25%)
Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices GlobeNewswire - Tue Feb 4, 8:00AM CST

FEMY : 1.1900 (-3.25%)
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control GlobeNewswire - Thu Jan 30, 7:30AM CST

FEMY : 1.1900 (-3.25%)

Barchart Exclusives

Should You Buy the Dip in Apple Stock in April 2025? Barchart - Sat Apr 5, 6:00AM CDT
Here is what you should do as Apple falls 22% from its 52-week high. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot